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INTRODUCTION 
More than 100 cases of laryngeal malignancy is being detected each year in 
upgraded institute of otorhinolaryngology Department, Madras Medical College 
Chennai. So the burden cases of carcinoma of larynx is ever increasing. 
Madras Metropolitan tumour registry, a population based cancer registry in 
chennai states that as of 2002, carcinoma larynx finds a place in top 10 cancers in men. 
Cumulative risk of getting ca larynx in their life time (0-74) is 1 in 208 and 1in 2000 in 
male and female respectively. ca larynx affects both sex with male preponderance 
which affects essential functions of larynx like speech and respiration and causes death. 
It is Mandatory to evaluate about the prognostic factors and treatment modalities 
is of prime importance.  Predicting the favourable prognostic factors and choosing 
correct line of management is of paramount importance to increase the survival rate. 
In the era of organ preservation not all cases are subjected to surgery. So 
radiotherapy is the preferred treatment for most cases. But Radiotherapy carries the risk 
of residual or recurrent growth. This Dissertation analysis the prognostic factors and 
treatment modality adopted for 50 cases of our institute since 2004 and their survival 
rate after 2yrs. 
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AIM OF THE STUDY 
 
The present study on malignant lesions of larynx is undertaken to study 
 The distribution of laryngeal malignancy by age, sex and staging on 
presentation and known risk factors. 
 The different histopathological types and differentiation 
 Various treatment modalities adopted 
 Assessment of prognostic factors 
 Assessment of treatment outcome after 2 yrs.  
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Review of Literature 
Historical Review 
 Ullmann (1923) demonstrated the presence of viral particles by injecting cell free 
extracts from papillomatous tissue. 
 Jackobasson (1976), in his studies in Karolinska Institute in Stockholm, devised 
score system of grading the malignant potential of tumous. 
 Batsakis (1979) showed strong association between carcinoma of larynx and 
cigaratte and pipe tobacco smoking. 
 Crissman (1979) used the term keratosis, because excess keratin formation is a 
common feature of the changes observed in laryngeal malignancy. He divided it 
into three groups according to its severity as keratosis, low grade dysplasia & high 
grade dysplasia. 
 Bukley et al (1982) identified three grades of morphological (histological) 
abnormalities as laryngeal intra epithelial neoplasia (LIN). The changes of LIN 
are considered to be a morphological manifestation of a neoplastic process, not a 
precancerous lesion. 
 Manguso and Hanfo (1982) have done extensive study of the larynx by using 
computerized tomography in benign tumours and laryngeal trauma. In cases of 
tumour extension, CT has made in possible to detect, Spread to anterior 
commisssure, Deep extension to paraglottic, para anytenoid areas, pre epiglottic 
spaces, Cartilage invasion, Extension of pyriform fossa tumours. 
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 Neuman and Byers (1982) in this study in otorhinolaryngology recorded the peak 
incidence of age was between fifth and sixth decade for laryngeal carcinoma. 
 Rothman (1982) described cancer epidemiology and prevention of laryngeal 
tumours. 
 Ogura et al (1983) showed the laryngeal carcinoma patients are always heavy 
smokers and incidence of metastases is 5 - 10%. Thirty fold risk of developing 
larygeal squamous cell carcinoma for men smoking atleast a pack and a half of 
cigarettes per day for more than Ten years. 
 Cummings et al (1996) showed the factors involving the malignant tumours of 
larynx and hypopharynx. He also reported that all of the patients develop 
squamous cell carcinoma were documented as reflux into laryngo pharynx. 
 Singh et at (1996) described the basaloid-squamous carcinoma a distinct 
histological entity. It is a variant of squamous cell carcinoma and it is 
preferentially located in the larynx especially in supraglottic sites. Recurrence rate 
is higher than the control group. These indicates post operative irradiation should 
be taken into consideration. 
 Reddy et al (1997) showed 75% to 95% of cure rate in small laryngeal cancers 
depending on thesite, tumour bulk, and degree of infiltration. 
 Me Caffrey et all (1998) described verrucous carcinoma of larynx - a variant of 
squamous cell carcinoma. most patients are men aged twenty nine to eighty with a 
peak incidence between fifty and sixty nine years and very high proportion to 
smokers. 
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 Yilmaz et al (1998) has described the prognostic factors that include, sex, age, 
pathologic features of tumour. The most important adverse factors for laryngeal 
cancers include increasing T stage and M stage. 
 Laccourreye (1999) has done conservative modality of treatment in patients with 
stage I-II squamous cell carcinoma of glottis. 
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APPLIED ANATOMY OF LARYNX 
Alterations in the functions of larynx have a significant impact not only on the 
respiratory physiology but also on that of deglutition. 
Anatomically the larynx consists of3 regions - supraglottis, glottis and subglottis. 
Each region is anatomically and embryologically distinct with separate lymphatic 
channels. Cancer of each region is therefore different in terms of its presentation, 
growth patterns, spread, treatment and prognosis. 
Supraglottis: The sites included in the supraglottic region are the epiglottis, the 
aryegpiglottic folds and the arytenoids. Inferiorly lie the false cords and the ventricle 
which separate the supraglottis from the glottis. Ths suprglottis has a rich lymphatic 
network. Lymphatics from this region exit through the thyrohyoid membrane along with 
the superior larygeal vessels into the jugulodigastric lymph nodes. Spread occurs early 
in this region. 
Glottis: The glottis consists of the rihght and the left vocal cords uniting 
anteriorly to form the anterior commissure. The vocal cord is membranous in its anterior 
two-thirds consist of vocalis muscle and its overlying epithelium. The posterior one-
third is cartilaginous, made up of vocal process of the arytenoid. The glottis extends 
inferiorly for a distance of 5mm where it is continuous with the subglottis. Glottis 
extends between superior and inferior arcuate lines. At the line of junction, the 
squamous epithelium changes to columnar epithelium. The lymphatics of the true vocal 
cord are sparse. Lymphatics from the glottis and subglottis pass through the circothyroid 
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ligament and drain into the prelaryngeal (Delphian) nodes, paratracheal nodes and the 
deep cervical nodes along the inferior thyroid artery. 
Subglottis: This consists of a mobile part from below the true vocal cords to the 
upper border of the cricoid cartilage (mucosa covering conus elasticus) and a fixed part 
which extends upto the inferior border of the cricoid. 
Reinke’s Space: This is a submucosal space between the mucosa of the glottis 
and the underlying vocalis muscle. It acts as a bursa allowing the mucosa to slide over 
the underlying tissues producing fluency in normal speech. The mucosa of the vocal 
cord can therefore be stripped of without causing damage to the underlying soft tissues 
with practically no alteration in the quality of voice. 
Pre-epiglottic Space of Boyer : This is a fat-filled space lying between the hyoid 
bone and thyrohyoid membrane anteriorly and the infrahyoid epiglottis posteriorly, 
hyoepiglottic ligament superiorly. Tumour invasion of this space signifies adanced 
disease and is staged as T3 in the TNM classification. The space is rich in lymphatics 
and relatively radioresistant because of the sparse blood supply. The space is continuous 
on either side, with the paraglottic space deep to the quadrangular membrane. 
Paraglottic Space of Tucker: The paraglottic space is a paired space between the 
conus elasticus and quadrangular membrane medially and the thyroid cartilage laterally. 
The paraglottic space contains the thyro-arytenoid muscle. Infiltration of this space 
causes fixity of the vocal cord by involvement of this muscle. Inferolaterally this space 
is continous with the gap between the thyroid and cricoid cartilage permitting the 
tumour an easy exit route to extralaryngeal spread. 
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Blood Supply: 
Larynx above the vocal folds is supplied by superior laryngeal artery a branch of 
superior thyroid artery. The superior laryngeal veins drain drain into the superior 
thyroid veins. 
Below the vocal cords by the inferior laryngeal artery a branch of inferior 
thyroid artery. Inferior laryngeal vein drain into the inferior thyroid vein. 
Nerve Supply: 
The innervation of the larynx is through vagus by superior and recurrent 
laryngeal nerves. All intrinsic muscles of larynx are innervated by the recurrent 
laryngeal nerve except for cricothyroid which is innervated by external laryngeal nerve. 
Sensory by internal laryngeal nerve innervating mucous membrane up to the 
level of vocal cords. The recurrent laryngeal nerve supplies it below the level of the 
vocal cords. 
Lymphatic Drainage: 
The lymphatics of the larynx are separated by the vocal folds into an upper and 
lower group. The part of the larynx above the vocal folds is drained by vessels which 
accompany the superior laryngeal vein, pierce the thyrohyoid membrane and empty into 
the upper deep cervical lymph nodes: whereas the zone below the vocal folds drains, 
together with the inferior vein, into the lower part of the deep cervical chain often 
through the prelaryngeal and pretracheal nodes. The vocal folds are firmly bound down 
to the underlying vocal ligaments and this results in an absence of lymph vessels, a fact 
which accounts for the clearly defined watershed between the upper and lower zones. 
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Supraglottis drains through vessels which accompany the superior laryngeal 
pedicle through the thyrohyoid membrane to reach the upper deep cervical nodes. 
The lower system drains directly into the deep cervical nodes through vessels 
which pass through or behind the cricothyroid membrane or drain into the prelaryngeal, 
pre tracheal or paratracheal nodes before reaching the deep cervical nodes. 
Nodal levels as followed at Memorial Sloan-Kettering Hospital 
Level I :  Submental and submandibular groups 
Level II :  Upper jugular group 
Level III:  Middle jugular group 
Level IV :  Lower jugular group 
Level V:  Posterior triangle group 
Level VI:  Anterior compartment group (visceral group) parathyroid, pretracheal, 
prelaryngeal etc. 
Lever VII :  These are nodes of the upper anterior mediastinum 
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AETIOLOGY OF LARYNGEAL MALIGNANACY: 
No single factor has been decisively proven to produce laryngeal carcinoma in man. 
Smoking and excessive alcohol intake are frequently encountered in patients with 
laryngeal and hypopharyngeal carcinomas. Some studies have implicated some racial 
predilection, urban dwellers, radiation exposure, asbestos, laryngeal kerotosis and 
leukoplakia, air pollution, Unidentified social and possibly genetic factors, and 
uncommon occupational influences, as a predisposing factors, but convincing proof is 
lacking”. Second Primary is Possible because of  common etiology 
a. Smoking: Smoking is a strong risk factor for the development of laryngeal 
cancer. In two separate studies it was found that 96.5% and 97.2% respectively 
of patients with laryngeal Cancer were smokers. Men smoking at least a pack-
and-a-half cigarettes per day for more than 10 years have a relative 30 fold risk 
of developing laryngeal Carcinoma. The risk of cancer from tobacco usage 
appears to be strongest for current smokers, and it declines markedly when 
smoking is stopped 
b. Tobacco Chewing: Tobacco has long been implicated as an important 
etiological agent in the development of larynx malignanacy.  
c. Alcohol (Ethanol): Many studies shows that consumption of all types of alcohol 
considered an another important risk factor. The relative risk of alcohol drinkers 
(compared with non drinkers) develop laryngeal carcinoma was increased 2.2 
fold. Another source of alcohol that has been associated with Aero-digestive 
squamous cell carcinoma  is available as mouth washes, the ethanol content of 
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which may range upto 28%. The dose related increase in risk of laryngeal 
squamous cell carcinoma in alcohol is almost equivalent to smoking. 
d. Occupation: The development of laryngeal cancer related to occupational 
factors appears to relatively uncommon and not well documented, as compared 
with other work related to head and neck cancer. All labourers expect agriculture 
and semiskilled workers (such as factory workers) were in greater risk than 
professionals. Exposure to asbestos, wood dust and cement dust, isopropyl 
alcohol, leather working, metal processing, mustard gas, nickel / nickel refining, 
sulfuric acid/other acids, textiles fibres/processing, coal and tar products have 
reported in some studies. 
e. Diet and Vitamin Deficiency: Diet and vitamin deficiency also attributed 
especially vitamin A deficiency and Vitamin C and protease inhibitors. A study 
evaluating the effect of cruciferous vegetable (such as cabbage and broccoli) 
containing insoles and flavinoids, which are known to inhibit the development 
of chemically induced cancer, showed that a high intake of these vegetables 
decrease the risk of laryngeal carcinoma. 
f. Irradiation Exposure :  The relationship between irradiation and the 
subsequent  development of squamous cell carcinoma has been strongly 
suspected. The development of laryngeal cancer following irradiation for 
thyrotoxicosis and has been reported. Ex smokers are more prone to this type of 
lesions, possibly reflecting the importance of other carcinogenic risk factors. 
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g.  Viral Factors: The Human Papilloma Virus (HPV) is recognized as an 
etiological factor in laryngeal cancer. Usually all the patients developing 
squamous cell carcinoma were cigarette smokers and reflux into 
laryngopharynx. Smith studied relationship between Human Papilloma Virus 
and laryngeal cancer. Human Papilloma Virus type found laryngeal include 
subtypes 6,11,16,18,30 and 33, Different HPV types have been graded as high 
risk types (16 and 18) medium risk (30 and 33) and low risk (6 and 11). There is 
storng association with HPV sub types 6 and 11 for laryngeal papillomatosis and 
SCC arising in the pre-existent benign papillomas associated with same types. 
HPV 16, is more potent subtype associated with the verrucous sub type of SCC 
of the aero digestive tract. HE showed cancer and leukoplakia patients are older 
than controls and patients were to be chronic smokers or alcoholics. Study 
shows glottic SCCs show a higher human papilloma-high risk oncogene 
positivity than do the supraglottic SCCs and the hypopharynx shows the lowest 
positivity rate. 
h. Gastro– esophageal Reflux: Laryngo pharyngeal reflex has received increasing 
attention as possible co – factor in laryngeal carcinogenesis. 
Risk Factors for laryngeal Cancer 
One hundred and seven patients afflicted with incident laryngeal cancer and 290 
controls with diseases considered not related to tobacco and alcohol exposure were 
interviewed in the Universiy Hospital of Montevideo, Uruguay. The study showed that 
smoking to be a strong risk factor, with a risk ratio35 times that of non-smokers. 
Alcohol exposure displayed lesser effects but its interaction with tobacco smoking 
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resulted in very high risks (more than 100 times higher). Among particular types of 
alcoholic beverages, red wine showed risk ratios similar to those displayed by hard 
liquor consumtion. The habit of drinking a local tea called “mate” was associated with a 
threefold increase in risk, after controlling for the effects of age and tobacco and alcohol 
consumption. Infrequent consumption of vegetables and fruits showed risk ratio of on 
the order of 2.7, suggesting a role of diet in the causation of laryngeal cancer. 
Multifactorial Theory of Squamous Cell Carcinogenesis 
It is apparent that the risk factors may be inter connected, and that they may play 
complementary, even synergistic, roles in laryngel carcinogenesis. It is the distinct 
actions of these risk factors that fit a new multifactorial model of carcinogenesis in 
which mucosal inflammation, injury and / or infection play a critical role. 
Classic carcinogenic theory relates to the dysregualtion of cellular growth and 
differentiation, carcinogenesis cause susceptible cells to undergo this dysregulation of 
growth and differentiation, which is termed malignancy. Initiation and promotion are 
the two recognized stages of carcinogenesis. Initiators are those carcinogens acting in 
the early phase of transformation; promoters act during the more variable late phase, 
within the latent time prior to malignant change. 
Clinical observation suggest that HPV is exclusively an infection of squamous 
epithelium; it grows on skin, on squamous epithelial surfaces of aero digestive tract 
such as the nose and larynx, when it occurs in the tracheobronchial tree and lung, 
Squamous metaplatia of the normal epithelium is almost always found. Such metaplasia 
may be exacerbated by smoking, reflux or any other cause of chronic inflammation. 
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Whether HPV infection is a prerequisite for squamous carcinogenesis at all of the sites 
of its occurence remains to be seen. 
Presently, tobacco is an important co-factor in laryngeal carcinogenesis, so too, 
preflex may be a very important co-factor. Ethanol appears to be greater risk factor, 
compared with tobacco; for the development of supraglottic squamous cell carcinoma. 
Because ethanol is not inhaled, it probable has little direct contact with the laryngeal 
mucosa. One might speculate that is exerts its effects by altering the immune status of 
the host, by predisposing to reflux or by both mechanisms. 
In conclusion the relationship between HPV infection and environmental factors 
such as pollution, occupational exposures, tobacco smoke and reflux may yet prove to 
be profoundly interactive and Etiology and pathogenesis of laryngeal carcinoma may 
proved to be truly multifactorial. 
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EPIDEMIOLOGY 
Total number of cases of carcinoma larynx in 2004 is 105 in our hospital 
COMMON CANCERS (2002): CIR AND TREND (1982-2002) 
IN MMTR, MALE 
 
Common 
cancers in 2002 
1982-1986 1987-1991 1992-1996 1997-2001 2002 
Stomach 9.5 9.9 10.1 10.1 10.3 
Lung 5.1 7.5 8.1 8.6 9.2 
Oral caity* 5.0 5.7 5.8 6.1 7.6 
Oesophagus 4.5 6.5 6.2 7.3 7.3 
Lymphoma 3.8 4.3 4.1 4.7 5.8 
Leukemia 2.6 2.6 3.4 3.5 4.9 
Oropharynx* 3.3 4.6 4.4 4.8 4.7 
Brain & CNS 1.9 2.0 2.5 2.7 3.8 
Hypopharynx 3.1 4.1 4.0 4.2 3.4 
Larynx 2.8 3.2 3.2 3.9 3.2 
 
CIR: Crude Incidence Rate / 100.000 
   UICC Classification 
 
 Above table shows that carcinoma Larynx is among the top 10 cancers 
according to Madras Metropolitan Tumour Registry. Also the incidence is ever 
increasing. 
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PATHOLOGY & HISTOLOGY: 
Laryngeal carcinoma constitutes approximately 2.5% of all head and neck malignancies. 
A slight increase in the incidence has been noted in the past two decades. 80% of 
laryngeal carcinoma occurs in the elderly in the fifth, sixth, seventh decades of life. A 
preponderance is noted in the males but this difference is decreasing because of increase 
in the number of female smokers. Post cricoid malignancy is seen more commonly in 
females than males. 
The pathology of laryngeal cancer is very complex. It may be considered under the 
following headings: 
Sites of incidence 
Histological types 
Histological grading 
Spread of malignancy 
Sites of incidence: Tumour incidence in different locations of the larynx varies. Most 
lesions occur in the glottic region followed by the supraglottis and subglottic regions in 
that order. 
Glottic -  76% 
Supraglottic - 19% 
Subglottic - 5% 
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The laryngeal tumours may be 
A. Epithelial 
I. Squamous cell carcinoma – predominantly 
II. Verrucous Carcinoma 
III. Spindle cell carcinoma 
Basaloid squamous cell carcinoma 
B. Non epithelial 
I. Adenoid cystic carcinoma 
II. Neuro endocrine carcinoma 
III. Malignant histiocytoma 
IV. Osteo sarcoma 
V. Rhabdomyo Sarcoma 
VI. Fibro sarcoma 
VII. Haemangio sarcoma 
VIII. Malignant Schwanoma 
IX. Chondro sarcoma 
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C. Lympho Proliferative Neoplasms 
1. Extramedullary plasmocytoma 
2. Lymphoma 
3. Melanoma 
D. Metastatic Lesions from 
1. Renal cell carcinoma 
2. Breast carcinoma 
3. Melanoma 
Histological types: Macroscopically, the growth could be exophytic, (proliferative), 
ulcerative or infiltrative. The most common type of tumour is the squamous cell 
carcinoma. Other rarer types of malignancy are: 
Adeno Carcinoma   Malignant lymphoma 
Adenoid Cystic Carcinoma Fibrosarcoma 
Chondrosarcoma   Plasmacytoma 
Transitional cell Carcinoma Malignant melanoma 
Microscopically they are graded as, well differentiated, moderately differentiated 
and poorly differentiated by Broder’s classification – Glottic tumours are usually 
very well differentiated. 
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Premalignant and early malignant laryngeal lesions: 
Papillomas : They are well circumscribed, benign neoplasms of the lining 
squamous epithelium. There are two main varieties, juvenile and adult types. HPV 
virus is main etilogical factor. Juvenile papillomas are soft, Mobile, pale pink, 
lobulated and 2-5mm in diameter and multiple. Histologically, lesion consists of 
multiple, small, papillary processes, lined by thickned prickle cell layer without 
cellular atypia. Malignant transformation may be observed after irradiation. Adult 
papilloma is single, occurs in 2-3% of cases. HPV antigenic material was 
demonstrated in tissue sections of the tumours. 
Keratosis : It is a form of hyperplasia of laryngeal epithelium They are often the 
outcome of chronic irritation. Histopathologically two forms of keratinisation are 
seen:- orthokeratosis – keratinized cells have shed their nuclei. Parakeratosis – the  
Nuclei are pyknotic at the center of the cell. The incidence of carcinoma following 
keratosis is below five percent. 
The descriptive terms, currently advocated by the W.H.O. are as follows 
Hyperplasia 
Keratosis 
Mild dysplasia 
Moderate dysplasia 
Severe dysplasia 
Carcinoma in situ 
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Crissman recommended a system analogous to that used in the uterine cervix for 
cervical intraepithelial neoplasia. This was termed laryngeal intraepithelial neoplasia 
(LIN). 
LIN I : mild dysplasia and keratosis 
LIN II : moderate dysplasia and intracellular dyskeratosis 
LIN III : severe dysplasia and carcinoma in situ. 
Carcinoma In situ and Carcinoma In situ with micro invasion 
In Carcinoma in situ of larynx there is full thickness replacement of the epithelium 
by cells with malignant cytologic features but no invasion beyond basement 
membrane. Grossly one cannot differentiate from keratosis or keratosis with cell 
atypia (leukoplakia). If it is left, it may go for invasive carcinoma. The rate of larynx 
preservation was seven times higher than reported after radio therapy without local 
recurrence in these cases. 
Squamous cell carcinoma 
This is the most commonly encountered tumour in the larynx. The incidence is 
around 1% of all cancers. 2% of all cases of Head and neck cancer are squamous cell 
carcinoma. The male predominance is high. The age range varies form third to ninth 
decade. The peak incidence is seventh decade. The incidence is seventh decade. The 
incidence is much higher among urban dwellers than those reside in rural areas. To label 
a malignancy as squamous cell carcinoma certain distinguishing and specific futures of 
normal squamous epithelium must be present at the light microscopic level. 
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(i) Formation of Keratin – extra cellular or intra cellular 
(ii) The presence of inter cellular ‘bridges’ 
Verrucous Carcinoma (Ackerman’s Tumour) 
Exophytic, fungating, brodly, implanted with many heavy broad filiform 
projections, it is located in vocal cords. Microscopically thickened papillomatous folds 
covered with well-differentiated keratinizing squamous epithelium. Slowly growing and 
locally aggressive, clinically malignant. It does not spread by metastasis, destruction of 
the cartilage may be present. Treatment is surgical excision with complete removal of 
the tumour with adequate margin. Radiotherapy is contraindicated as it may change into 
anaplastic carcinoma. 
Pseudo Sarcoma 
Shows squamous cell carcinoma and sarcoma in the same region. Appearance is 
multiple polypoid lesion with ulcerated mucosa. Histalagical difference is present 
between primary and secondary sites  
Basaloid Squamous cell carcinoma 
Most frequently arises in supra glottis and hypopharynx. Prominent nuclei and 
scant cytoplasam and carries worse prognosis because of frequent distal metastases. 
Histological Grading: 
Degree of differentiation : The extent to which a squamous cell cancer retains the 
distinguishing features of normal stratified squamous epithelium determines the degree 
of differentiation. Accordingly Broder proposed a grading as well, moderate and poorly 
differentitated. 
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Well differentiated type: The individual tumour cell and nests show considerable 
similarity to normal stratified squmous epithelium. “Pearl” – a nest of cells some of that 
in whorled fashion with the central cells having more abundant eosinophilic cytoplasm 
than the peripheral cells and often showing central keratinization. 
 
Moderately differentiated type : Considerable anaplasia is seen. Resemblance to 
normal stratified squamous epithelium is slight. 
 
Poorly differentiated type: Considerable anaplasia is seen. Resemblance to normal 
stratified squamous epithelium is slight. 
 
Grades % of Cell Undifferentiated 
Well Differentiated 0-25 
Moderately differentiated 25-50 
Poorly Differentiated 50-75 
Undifferentiated 75-100 
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Spread of malignancy 
  Supraglottic Tumours : Aryepiglottic fold is the commonest site of 
involvement.  Mostly exophytic tumours tend to remain localized for longer time.  
Supra glottic tumours are more apt to have pushing rather than invasive borders. 
Mode of Spread 
Superiorly   : Submucosa of Vallecula 
Anteriorly  : Through holes in the epiglottic cartilage to the pre  
epiglottic space. 
Inferiorly  : False cords; through paraglottic space to true vocal cords  
and subglottic. 
Malignant growth from false cords laterally go to pyriform fossa.  
Supraglottic tumours grow in the direction of the flow of submucosal lymphatics. 
Glottic Tumours : in the glottis malignancy has a predilection for the 
anterior half of vocal cord and the anterior commissure. 
Mode of Spread 
Free margin of vocal cords 
 
Reinke’s space involvement 
 
 
Through the space – entire length of vocal cord 
 
Anterior commissure 
 
 
 
Subglottic 
Extension+      Opposite Cord   Cartilage Invasion 
Involving thyroarytenoid 
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Subglottic 
 Primary tumours of subglottic region are rare. They are mostly extensions from 
glottis and characterized by circumferential and infiltrating growth, cartilage invasion 
and penetration of cricothyriod membrane. Symptoms are airway obstruction.  
Mode of Spread 
Superiorly : Glottis 
Anteriorly : Through cricothyroid membrane to grow outside 
the laryngeal framework 
Inferiorly : Trachea 
 Trans Glottic Tumours: Tumours surrounding laryngeal ventricle (involving 
glottis and supraglottic regions). These are characterized by infiltrative growth pattern 
with frequent cartilage invasion and poor prognosis. 
 Barriers for spread of tumours: Pattern of growth and spread of laryngeal 
cancer are found to be influenced by fibro elastic ligaments and membranes. 
1. Anterior commissure tendon 
a. Midline barrier for spread of glottic tumours 
b. It is the confluence of vocal ligament, thyroepiglottic ligament, conus 
elasticus and internal perichondrium of thyroid ala. 
2. Conus elasticus – Barrier for spread to subglottic region 
 quadrangular membrane forms barrier to supra glottis region. 
3. Ventricles – Barrier for spread to supraglottis 
4. Thyroid cartilage 
5. Cricoid cartilage 
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 Adenoid Cystic Carcinoma : Laryngeal adenoid cystic carcinoma (ACC) is 
rare and probably arises from endogenous seromucinous glands. Most laryngeal ACCs 
are either  subglottic or supraglottic. Microscopically the tumour is characterized by 
tubular, cribriform and solid growth pattern. The solid growth pattern has wrose 
prognosis. ACC is infiltrative and has perineural invasion, which present with pain in 
patients. ACC commonly metastasis to lung and bone. Surgical excision with adjuvant 
radiotherapy is the treatment of choice.  
 Neuroendocrine Carcinomas: Three types of neuroendocrine carcinomas 
occur (i) typical carcinoid (well differentiated neuro endocrine carcinoma), (ii) atypical 
carcinoid (moderately differentiated neuro endocrine carcinoma), and (iii) small cell 
carcinoma (poorly differentiated neuro endocrine carcinoma). 
 Typical Carcinoid of the larynx is an extremely rare tumour with a strong male 
predominance. Microscopically it is characterized by islands, nests and ribbons of 
uniform small neoplastic cells lacking under nuclear atypia, mitotic figures or necrosis. 
Patients are usually treated by surgery.  
 Atypical Carcinoid is more common than typical carcinoid. Histologically these 
exhibit mild to moderate nuclear atypia, mitotic figures and single cell necrosis. They 
are immuno reactive for calcitonin, although the serum calcitonin level is rarely 
elevated. Forty percent of patients die with this disease. Surgery with or without 
adjuvant radiation and chemo therapy is the treatment of choice.  
 Small cell Carcinoma (Oat Cell Carcinoma) comprises 0.5% of primary 
laryngeal malignancies. The neoplastic cells are two or four times the size of a 
lymphocyte. Nucleus have a finely granular chromatin, lack of nucleoli and increased  
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fragility of the cells. It is associated with a dismal prognosis. Radiation and 
chemotherapy are the treatment of choice.  
 Chondrosarcoma is rare slowly growing cartilaginous tumour. It is the most 
common malignant measenchymal laryngeal neoplasm. These are typically submucosal 
and mostly arise from cricoid cartilage. It is firm in consistency, and is characterized by 
hyper cellularity, nuclear atypia and double nucleated cells. Surgery is the treatment of 
choice. 
 Lymphomas account for less than one percent of all laryngeal neoplasms. There 
is no significant difference in incidence between the sexes. The condition occurs from 
fifth to seventh decade. It involves the supra glottic region in particular the epiglottis 
and aryepiglottic folds, the vocal cords may be involved. Macroscopically the tumour 
appears as swelling covered by intact edematous mucosa. Microscopically most 
laryngeal lymphomas are of lymphocytic types Hodgkin’s disease very rarely involves 
the larynx.  
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CLASSIFICATION AND STAGING: 
Laryngeal tumours can be classified according to the region. 
1. Supraglottic 18% 
2. Glottis 76% 
3. Subglottic 6% 
TNM classification of carcinoma of larynx. 
Rules for Classification 
The classification applies only to carcinoma. There should be histological verification 
of the disease. Any unconfirmed cases must be reported separately. The minimum 
requirements for assessment are: 
T (site)  : Clinical examination, laryngoscopy and radiography 
N (node)   : Clinical examination 
M (Metastasis) : Clinical examination and radiography 
X indicates that the minimum requirements for assessment cannot be met. 
Anatomical regions and sites 
1. Supra Glottis 
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Epilarynx including Marginal Zone 
i. Posterior surface of suprahyoid epiglottis (including the tip) 
ii. Aryepiglottic fold 
iii. Arytenoid 
Supraglottic Excluding Epilarynx 
iv. Infrahyoid epiglottis 
v. Ventricular bands 
vi. Ventricular cavities 
2. Glottis 
i. Vocal cords 
ii. Anterior commissure 
iii. Posterior commissure 
3. Sub Glottis 
Regional lymph nodes 
The regional Lymphnodes are the cervical nodes. 
TNM Pre Treatment Classification by UICC 1987 
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T. Primary Tumour   
Supra Glottis 
Tis Preinvasive carcinoma (carcinoma in situ)   
T0 No evidence of primary tumour 
T1 Tumour confined to the region with normal mobility of vocal cords. 
T1a Tumour confined to the laryngeal surface of epiglottis or to an aryepiglottic fold 
or to a ventricular  cavity or to a ventricular band. 
T1b Tumour involving the epiglottis and extending to the ventricular cavities ir 
bands. 
T2 Tumour confined to the larynx with extension to adjacent site or sites or to the 
glottis without fixation. 
T3 Tumour confined  to the larynx with fixation and/or other evidence of deep 
infiltration.  
T4 Tumour with direct extension beyond the larynx. 
Glottis 
Tis Preinvasive carcinoma (carcinoma in situ)   
T0 No evidence of primary tumour 
T1 Tumour confined to the region with normal mobility 
T1a Tumour confined to one cord 
T1b Tumour involving both cords 
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T2 Tumour confined to the larynx with extension to either the supraglottis or the 
subglottic regions with normal or impaired mobility. 
T3 Tumour confined to the larynx with fixation of one or both cords 
T4 Tumour with direct extension beyond the larynx or thyroid cartilage invasion. 
Sub Glottis 
Tis Preinvasive carcinoma (carcinoma in situ) 
T0 No evidence of primary tumour 
T1 Tumour confined to the region 
T1a Tumour confined to one side of the region 
T1b Tumour with extension to both sides of the region 
T2 Tumour confined to the larynx with extension to one/or both cords with normal 
or impaired mobility. 
T3 Tumour confined to the larynx with fixation of one or both cords 
T4 Tumour with destruction of cartilage and /or with direct extension beyond the 
larynx. 
N- Regional lymph Nodes 
Nx  Regional lymph nodes cannot be assessed 
N0 No regional lymph node metastasis 
N1 Metastasis in a single ipsilateral lymph node 3 cm or less in greatest dimension. 
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N2 Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 
6 cm in greatest dimension, or in multiple ipsilateral lymphnodes none more 
than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes 
none more than 6 cm in greatest dimension.  
N2a Metastasis in a single ipsilateral lymphnode more than 3cm but none more than 
6cm in greatest dimension. 
N2b Metastasis in multiple ipsilateral lymphnode none more than 6cm in greatest 
dimension. 
N2c Metastasis in bilateral or contralateral lymph node none more than 6 cm. 
N3 Metastasis in a lymphnode more than 6cm in greatest dimension. 
 32 
M- Distant Metastasis 
M0  No evidence of distant metastasis 
M1  Evidence of distant metastasis 
Mx The minimum requirements to assess the presence of distant metastasis cannot 
be met.  
STAGING 
Stage I T1 N0 M0 
Stage II T2 N0 M0 
T1 / T2 / T3 N1 M0 Stage III 
T3 N0 M0 
Stage IV A T4 N0 M0 
Stage IV B Any T N2 / N3 M0 
Stage IV C Any T Any N M1 
 
Differential diagnosis: 
1. Fungal laryngitis,  
2. TB larynx,  
3. sarcodosis,  
4. wegeners granulomatosis. 
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Investigation: 
1. Routine Blood examination 
2. X- ray chest – To look for secondaries and for GA fitness 
3. X-ray Neck soft tissue lat view – To look for sub glottic air column and any 
widening of prevertebral  soft tissue. 
4. Ultrasound Neck – Thyroid gland involvement  and neck secondaries. 
5. Ultrasound Abdomen – To look for secondary deposits in liver. 
6. CT Scan Neck – To see Pre epiglottic space, para glottic space, cartilage 
invasion. 
7. Direct laryngoscopy – To know the extent of disease and biopsy 
8. Barium swallow 
CT Criteria for positive nodes: 
- More than 1 cm diameter 
- Spherical 
- Peripheral rim enhancement with contrast and central 
necrosis. 
- Extra capsular spread  
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Management Protocol: 
1. For carcinoma in situ: When lesions clearly show hyperkeratosis with atypia 
and often CIS, management can be conservative if a satisfactory strip of cord is 
removed. The gross lesion should be removed, requiring frequent follow-up and 
rebiopsy 6 to 12 weeks later if needed. 
2. For T1 and T2 lesion – Radiotherapy is  the Ist choice of treatment 
3. For T3 lesions – Total laryngectomy with or without primary TEP  
4. For T4 lesions  - Salvage Surgery 
  Post operative radiotherapy for T3 and T4 cases with or without nodal 
secondaries. For cases with advanced disease like stage IV, palliative radiotherapy with 
chemotherapy is given. Also cases who are not fit medically, are given RT. 
Involvement of Thyroid cartilage is contra indication for RT. 
  Local cure by radiotherapy for glottic tumors, which most always matches 
tumor-free survival, has not changed since 1974 when Fletcher and Jesse noted 85% 
control rate until 1996 when McLaughlin and others noted 89%. Surgical management 
of radiation failures resulted in a 60% salvage rate with a 70% salvage rate reported by 
Biller and Lawson and a 95% salvage rate reported by Rothfield and others. The latter 
result is achieved when partial surgery can be performed despite radiation failure.  
  No clear advantage of surgery versus radiotherapy is noted in the literature for 
early glottic tumor, and local mores and abilities should prevail. Surgery is more 
successful for lesions with subglottic extension and impaired vocal mobility. 
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Postradiation edema for longer than 6 months has a 45% association with deeply 
invasive recurrence and requires follow-up by endoscopy and imaging.  
  Post operative radiation is advised for cartilage destruction, subglottic 
extension, thyroid gland involvement or positive paratracheal nodes. 
Prognotic Factors  
Tumor Factor: Tumor Grade:  
 Poorly differentiated tumors carries worse prognosis. 
 It responds well to RT, but recurs.  
Tumor Border: 
 Infiltrating border carries worse prognosis than pushing border 
Surgical Margin: 
 Tumor free margin confirmed by frozen section carries better prognosis. 
Lymph node status: 
 Number, location, Extra Capsular Spread are important criteria. 
 Among these Extra Capsular Spread is the single most important criteria. 
Host Factor: 
 The type and degree of the host inflammatory response to tumor may bear on 
prognosis. Pronounced tumor- associated tissue eosinophilia (TATE), peritumoral 
Langerhans cell infiltration, and marked lymphoid inflammation have been touted as 
indicators of a good prognosis. Recently, however, the prognostic significance of 
TATE in LSCC has been disputed.  
 It is obvious that earlier the patient seeks medical advice, better is the prognosis.  
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PROFORMA OF THE CASE SHEET 
Study Serial No. OP.No. Unit IP No. Date of First Visit 
 
Follow up 
Dates 
1 2 3 4 5 6 7 8 
 
Name  :  Age :   Sex : 
Occupation :  Income:   Address: 
Diagnosis : 
I. Presenting Complaints 
Hoarseness of voice, Difficulty in breathing, Cough, Difficulty in swallowing, 
Pain, Fever, Swelling in the neck, Loss of weight, Any other complaints: 
II.  History of Presenting Illness 
Hoarseness of voice, Difficulty in breathing, Cough, Difficulty in swallowing, 
Pain, Fever, Swelling in the neck, Loss of weight, Associated complaints: 
III.  Past History 
- History of Tuberculosis / Syphilis / Leprosy / diabetes 
 - History of trauma / allergy / irridation 
Surgery for any other disease. 
IV.  Family History 
 - Similar complaints in any other member in the family 
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 - Death related with cancer in the family. 
IV. Personal History 
 - Habits:  Smoking, Paan / Beet at nut chewing, Alcohol intake 
V. Treatment History 
VII.  General Examination 
 Built, Nutrition, Mental Status, Pallor, Lymph – node status 
 Temperature, Pulse, Respiratory rate, Blood Pressure 
VIII.  Systemic Examination 
 Cardiovascular system, Respiratory system, 
 Per Abdomen, Central Nervous systems 
IX. ENT Examination / Local Examination 
1. Mouth : Lips, Teeth, Gum Margin, Palate, Floor of mouth 
   Pillars, Tonsils, Uvula, Posterior pharyngeal wall, Nasopharynx: 
 Throat : Indirect Laryngoscopy:-   Posterior 1/3 of tongue, Vallecula,  
   Epiglottis, Aryepiglottic Fold, Arytenoids, Ventriculars bands,  
   vocal cords, Anterior & Posterior commissure, Pyriform fossae 
and  
   Postcricoid region, External palpation of laryngeal cartilages 
 Examination of Neck 
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2. Nose : 
3. Ear : 
X. Provisional Diagnosis 
XI. Investigations 
a. X-ray Chest / Barium Swallow / X-ray Neck – Lateral view (soft tissue) 
b. Biopsy – during DL Scopy & HPE / USG / CT - Neck 
c. MLE & Biopsy for vocal cord lesion 
d. FNAC of Neck nodes. 
XII. Diagnosis 
XIII.  Management 
XIIII. Follow Up 
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Meterial and Methods 
This is an analytical, prospective, cross sectional study. An average of 400 cases 
attend the out patient department of our institute, Madras Medical College and 
Govrnment General Hospital, Chennai, daily. Of these 3 to 4 patients harbour 
malignancy of various sites in the head and neck region. 
Fifty consecutive cases with proven laryngeal malignancy who were admitted in 
ENT ward of this hospital were taken up for the study. 
Inclusion Criteria:- 
Only Histologicaly proven cases of ca larynx are taken up for study. 
Exclusion Criteria:- 
Patients with laryngo pharyngeal malignancy are excluded. 
Evaluation of the disease is done by history,  Clinical Examination using Indirect 
laryngoscopy. Neck examination, ultra sound or CT of neck, video laryngoscopy, 
Direct laryngoscopy & Biopsy for supra glottic lesion, Micro laryngial examination & 
biopsy for vocal cord lesion, FNAC for neck nodes. Most often radiological 
examination of neck up stages the disease. Endoscopy is used to visualise areas like 
laryngeal surface of epiglottis and anterior Commisures, which are usually hidden 
areas. 
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OBSERVATION AND DISCUSSIONS 
Site, Morphology & Staging: 
 The majority of the cases were Glottic carcinoma 60%. Supraglottic constitute 
32% and rest of the cases are Transglottic 6% and subglottic 2%. This study concurs 
with the standard literature. 
 Twenty eight patients had Proliferative fleshy lesions, another five cases were 
found to have UIcero proliferative lesions. Twelve cases had smooth mucosal surface.  
 As shown in the standard literature the carcinoma of the glottic region dominate 
in our study. Majority of the cases presented at T3 stage especially glottic carcinoma. 
Incidence by Site, T – stage and Nodel status (N=50) 
Anatomical Site Stage No. of  
cases 
% N 
Stage 
No.of  
Cases 
% 
T1 - - N0 0 0 
T2 4 25 N1 4 25 
T3 9 56.25 N2 8 50 
Supraglottic 16- cases 
T4 3 18.75 N3 4 25 
T1 8 26.7 N0 21 70 
T2 2 6.7 N1 8 26.7 
T3 18 60 N2 1 3.3 
Glottic 
30- cases 
T4 2 6.7 N3 - - 
T1 - - N0 - - 
T2 - - N1 1 33.3 
T3 3 100 N2 2 66.6 
Trans glottic 
3- cases 
T4 - - N3 - - 
Sub glottic 
1- case 
T4 1 100 N2 1 100 
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Discussion on the table  
i. 60% of the cases are glottic cancers. It is regrettable that majority of patients 
(18 cases) reached hospital when they reach T3 stage. 10 cases were in the 
T1 & T2 stages. Two patient presented in the T4 stage. Majority of glottis 
cancers patients  (21) presented with No, eight cases the N1 and one in N2 
stage. None presented with metastasis. 
ii. 32% are supraglottic cancers. 75 percent presented in T3, T4 stage only 25% 
presented in T2 stage. None came on T1 stage. None of the cases presented in 
N0 stage. 50% presented in N2 stage. This shows that supra glottis cancers 
have the predilection of nodal metastases. 
iii. All the trans glottic cases presented with Neck secondaries in N1 or N2 stage. 
iv. Only one case of sub glottic cancer found.  
Stage of the  diseases when presented is crucial in deciding the type of treatment 
to be given.  
 42 
HISTOLOGICAL FINDINGS IN THIS STUDY 
Broder’s classification when applied in our study the following pattern is observed. 
Differentiation No.of Cases Percentage 
Well differentiated 24 cases 48% 
Moderately differentiated 18 cases 36% 
Poorly differentiated 6 cases 12% 
Undifferentiated 2 4% 
 Since majority of the cases where glottic growth which have the tendency to 
present as well differentiated variety, as shown in the standard literature. In our study 
predominately more well differentiated variety (48%) is seen.  
ANATOMICAL SITE OF LESION AND DIFFERENTIATION WITH PERCENTAGE 
 Anatomical Site 
No.of cases 
Differentiation Percentage 
1. Supraglottis 
16 cases 
Well differentiated               - 4 
Moderately differentiated    - 4 
Poorly differentiated            - 2 
Un- differentiated                - 2 
25% 
25% 
12.5% 
12.5% 
2. Glottis 
30 cases 
Well differentiated               - 20 
Moderately differentiated    - 10 
Poorly differentiated            - Nil 
66.7% 
33.3% 
Nil 
3. Transglottis 
3 cases 
Well differentiated               - Nil 
Moderately differentiated    - 3 
Poorly differentiated            - Nil 
Nil 
100% 
Nil 
4. Subglottis 1 case Moderately differentiated    - 1 100% 
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DISTRIBUTION ACCORDING TO DEGREE OF 
DIFFERENTIATION 
 
48%
36%
12%
4%
Well Differentiated Moderately Differentiated
Poorly Differentiated Undifferentiated
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DISTRIBUTION ACCORDING TO ANATOMICAL SITE 
32%
60%
6% 2%
Supraglottis 16 Cases Glottis 30 Cases
Transglottis 3 Cases Subglottis 1 Case
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 Supra glottic  (25%) and glottic tumour (66.7%) are well differentiated variety. 
All the transglottic tumours were (100%) moderately differentiated. Cells nests are 
observed in 46 cases out of 50 cases (92%0 Inflammatory cell infiltration in the stroma 
are seen in all the cases. Predominantly neutrophils with macrophages and plasma cells 
seen in 26 cases 52%. These cases had presented with symptoms less than 6 to 9 
months. This may be due to acute tumour cell reactions. The other 24 cases had 
lymphocytes (48%) along with plasma and macrophages. This indicates chronic process 
initiating host response. These cases may have better prognosis.  
Type of Inflammatory Cell No.of Cases 
Sinus histiocytosis, follicular 
lymphoid hyperplasia, plasma 
cells 
33 
Lymphoid depletion 5 
Sinus histiocytosis, follicular lymphoid hyperplasia, plasma cells are associated 
with good prognosis.   
Lymphoid depletion is associated with poor prognosis.  
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Conventional Squamous Cell Carcinoma 
 Among the conventional squamous cell carcinoma 48% were well differentiated 
and 32% were moderately differentiated. Poorly differentiated is variety observed in 
two cases. These cases are presented with node involvement initially. Histologically it 
reveals elongated and fusiform neoplastic cells. The mitotic figures are more. The cells 
are highly pleomorphic and based on the morphological features it is classified as 
poorly differentiated squamous cell carcinoma. These patients are subjected to 
palliative radiotherapy. 
Mitotic Figures in our Study 
Mitotic Figures No. of Cases % 
Scanty 42 84 
Moderate 4 8 
High 4 8 
  
In undifferentiated carcinoma histological examination reveals sheets of 
neoplastic cells with hyperchromatic pleomorphic nuclei and eosinophilic cytoplasm is 
observed. Moderate amount of fibrovascular tissue surrounded with neoplastic cells. 
Scattered infiltration with mononuclear cells is observed in the stromal tissues. The 
treatment rendered is radiotherapy.  
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TREATMENT ADOPTED IN OUR STUDY 
Since Organ Preservation is the main aim nearly 50% of the cases are 
subjected to Curative Radiotherapy when they present with T1, or T2 stage 
without metastases. 
 In our study, out of 50 cases Curative radiotherapy is given for 22 cases 
who presented in early stage of the disease. Palliative radiotherapy with 
Chemotherapy given for 10 cases who presented with late stage of the disease.   
13 patients underwent Total Laryngectomy, out of which 12 patients were in the 
stage III and one in Stage IV. Ideally, most cases are glottic cancers with T3 
stage without nodal or distant metastases. Two cases underwent modified radical 
neck dissection along with Laryngectomy. 
 Five cases absconded from treatment.  There are eight cases of recurrence 
within the period of 2 years. Out of which one case was after Total 
Laryngectomy with modified radical neck dissection. That case was not 
subjected to post operative radiotherapy since that patient developed post 
operative Pharyngo cutaneous fistula and Subsequently he underwent 
myocutaneous flap transposition procedure. So we are unable to give 
Radiotherapy within about 4 months. 
 Two cases of recurrence occured after primary Radiotherapy for Glottic 
cancer T1 No Mo and T3 No Mo. Those patients underwent total Laryngectomy 
who is disease free till now.  Post radiation oedema of more than 6 months was 
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considered as the criteria for surgery  in first case.  Residual lesion was 
considered as the criteria for surgery for second case. 
 Remaining cases were given adjuvant Chemotherapy with Palliative 
procedures.  All the recurrent cases were presented with nodal metastasaes 
initially. Histologically lymphoid depleted cases of 5 went in for recurrence. All 
the poorly differentiated cases responded well to Radiotherapy. 
 Tumour Grade is not predicted as the important prognostic indicator as 
many literature studies shows 
 Adequate resection of tumour, leaving tumour free margin resulted in 
disease free survival till 2 years – Literature also concurs with this. 
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CONCLUSION 
 
• Primary Radiotheraphy given : 22 Cases 
• Surgery and Post Operative : 11 Cases 
Radio Theraphy 
• Surgery done for Radio : 2 Cases 
Recurrent Cases 
• Total No. of Recurrences : 8 Cases 
within the period of 2 years 
• 2 Years Survival Rate  : 82 %   
after curative RT and Surgery 
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 S.No. Name Age Sex Staging Treatment given 
1.  Kamalam 62 F T3 No. Mo Curative Radiotheraphy 
2.  Ravi 47 M T3 N2b Mo Palliative Radiotheraphy 
3.  Damotharan 75 M T2 No Mo Curative Radiotheraphy 
4.  Rangarajan 55 M T3 N2b Mo Palliative Radiotheraphy 
5.  Rajeswari 30 F T1 No Mo Curative Radiotheraphy 
6.  Elumalai 55 M T3 N2b Mo Total Laryngectomy with Neck Dissection 
with RT 
7.  Balavantha Rao 65 M T3 No Mo Curative Radiotheraphy 
8.  Dhanabal 55 M T3 No Mo Total Laryngectomy with RT 
9.  Krishnaiah 75 M T4 No Mo Palliative  RT with Chemotheraphy 
10.  Ragavaiah 55 M T3 No Mo Absconded 
11.  Abdul Rahman 70 M T2 No Mo Curative Radiotheraphy 
12.  Vijayaraghavan 60 M T4 No Mo Palliative Radiotheraphy 
13.  Manikandan 22 M T3 No Mo Curative Radiotheraphy 
14.  Kannan 55 M T1 No Mo Curative Radiotheraphy 
15.  Krishnan 69 M T3 No Mo Curative Radiotheraphy 
16.  Dawood 65 M T3 No Mo Total Laryngectomy with RT 
17.  Mohan 54 M T4 No Mo Total Laryngectomy with RT 
18.  Murugan 34 M T3 N1 Mo Curative Radiotheraphy 
19.  Poongavanam 56 M T2 No Mo Curative Radiotheraphy 
20.  Kuttiappan 68 M T2 No Mo Curative Radiotheraphy 
21.  Fathima 70 F T3 No Mo Palliative Radiotheraphy 
22.  Jayalakshmi 70 F T3 No Mo Total Laryngectomy with RT 
23.  Poongavanam 50 M T3 No Mo Total Laryngectomy with RT 
24.  Chinnappan 55 M T4 N3 Mo Palliative Radiotheraphy with 
Chemotheraphy 
25.  Prakash 40 M T3 N3 Mo Palliative Radiotheraphy with 
Chemotheraphy 
26.  Nagendran 45 M T3 N1 Mo Curative Radiotheraphy 
27.  Venkateshwaralu 29 M T1a No Mo Curative Radiotheraphy 
28.  Rajendran 40 M T1a No Mo Curative Radiotheraphy 
29.  Munusamy 70 M T2 N1 Mo Curative Radiotheraphy 
30.  Gopal 65 M T3 N2a Mo Total Laryngectomy with RT 
31.  James 55 M T3 N1 Mo Curative Radiotheraphy 
32.  Jagadesan 85 M T1a No Mo Absconded 
33.  Antony 50 M T1a No Mo Curative Radiotheraphy 
34.  Sundaram 75 M T4 No Mo Palliative Radiotheraphy with 
Chemotheraphy 
35.  Rajendran 57 M T3 N1 Mo Curative Radiotheraphy 
36.  Chinnasamy 65 M T3 N1 Mo Curative Radiotheraphy 
37.  Selvaraj 52 M T3 N3 Mo Absconded 
38.  Chelliah 65 M T4 No Mo Total Laryngectomy with RT 
39.  Kannan 63 M T3 N2c Mo Curative Radiotheraphy 
40.  Samboornammal 64 F T4 N2b Mo Palliative Radiotheraphy with Chemotherapy 
41.  Kesavan 57 M T3 N1 Mo Curative Radiotheraphy 
42.  Munusamy 57 M T3 N2c Mo Absconded 
43.  Rami Reddy 55 F T3 No Mo Curative Radiotheraphy with Total 
Laryngectomy 
44.  Shantha Kumar 62 M T4 N2b Mo Palliative Radiotheraphy with 
Chemotheraphy 
45.  Sivakumar 55 M T1a No Mo Curative Radiotheraphy with total 
Laryngectomy 
46.  Mani 57 M T3 N2a Mo Total Laryngectomy with MRND 
47.  Mohd. Ali 55 M T3 No Mo Total Laryngectomy with RT 
48.  Kasi 50 M T2 N1 Mo Curative Radiotheraphy 
49.  Moorthy 48 M T3 No Mo Total Laryngectomy with RT 
50.  Shanmugam 88 M T3 N3 Mo Palliative Radiotheraphy with 
Chemotheraphy 
   
